← Back to all trials
Recruiting
NCT05598879
Global Cardio Oncology Registry
Conditions: Breast Cancer, Hematologic Malignancy, Immune Checkpoint Inhibitor-Related Myocarditis, Cardiotoxicity, Cardiovascular Diseases
Sex: All
Ages: 18 Years – N/A
Enrollment: 5000
Sponsor: The Cleveland Clinic
Location: United States
Summary
G-COR is the first Global Prospective Cardio-Oncology Registry.
It is a multinational, multicenter prospective observational cohort registry, with the goal of collecting clinical, laboratory, imaging, demographic, and socioeconomic data to identify risk factors associated with increased incidence of cancer therapy related cardiovascular toxicity (CTR-CVT) in different settings and to derive and validate risk scores for cardio oncology patients treated in different geographic locations throughout the world.
Eligibility Criteria
Inclusion Criteria:New cardio-oncology consultation for breast cancer patients, orNew cardio-oncology consultation for Hodgkin's or non-Hodgkin's lymphoma patients, orNew cardio-oncology consultation for acute or chronic leukemia patients, orNew cardio-oncology consultation for multiple myeloma or AL amyloidosis, orNew cardio-oncology consultations for immune check-point inhibitors cardiac evaluation.All patients have to be 18 years old or olderExclusion Criteria:Cardio-oncology patients who have previously had cardio-oncology evaluation and follow up by the investigators.Minors less than 18 years old.Inability or unwillingness to consent to participate
Source: ClinicalTrials.gov (NCT05598879). StuddyBuddy aggregates publicly available trial information.